ReviewVaccines2024

A Comparison of the Immunogenicity and Safety of an Additional Heterologous versus Homologous COVID-19 Vaccination among Non-Seroconverted Immunocompromised Patients after a Two-Dose Primary Series of mRNA Vaccination: A Systematic Review and Meta-Analysis.

Chatchaya Nangsue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.